Target for Anti-Tumor Immune Responses

therapoid

  1. Home
  2. Technologies
  3. Target for Anti-Tumor Immune Responses
  4. Summary
Provided by: National Institutes of Health (NIH)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology pertains to the genotypic and phenotypic analysis of the 888 mel cell line in order to better understand the nature of tumor cells that respond to therapy.

Projects based on this Technology

Start New Project